ArticlePharmaceuticals (Basel, Switzerland)2024

Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease.

Marta Maggisano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.